Capital Group Growth ETF

TransDigm Group

Vertex Pharmaceuticals

Notable ETF Inflow: CGGR Sees $251.7 Million Increase in Shares Outstanding

TransDigmGroup

TransDigm Group's 15min chart sees MACD Death Cross and KDJ Death Cross.

Insider Selling Dominates at TransDigm Group: 58% of Holdings Sold

TransDigm Group's 15min chart shows Bollinger Bands expanding downward, KDJ death cross.

GE Aerospace

Morgan Stanley Boosts Aerospace Stocks: GE Aerospace and TransDigm to Buy on the Dip

Catalyst<ul> <li>Most analysts rate TDG Buy or Strong Buy, showing broad institutional optimism.</li> <li>Recent news highlights increasing strategic investments and growth opportunities in aerospace and defense manufacturing.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state, and the direction is not clear enough.</li> <li>Fund flows show negative trends for medium, large, and extra-large orders, indicating outflows by major investors.</li></ul>

Key Factors

TransDigm Group (TDG) experienced a trading volume of $760 million on March 30, 2026, a 64.89% increase from the previous day and the highest on the day. TDG's stock closed down 0.63% on March 30, 2026, trading below its 50-day and 200-day moving averages despite the surge in volume. The Capital Group Growth ETF (CGGR) reported a $251.7 million inflow on March 30, 2026, with TransDigm Group (TDG) among its holdings showing a 0.4% increase.

Recent Updates

TDG News